Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:52 AM UTC
| NCT Number | NCT05386108 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 73 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Stemline Therapeutics, Inc. |
| Last Updated on CT.gov | October 9, 2026 (6 days ago) |
As of October 15, 2026: Clinical trial NCT05386108 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Stemline Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05386108 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05386108 was last updated 6 days ago (October 9, 2026). HelloStudys verifies this status automatically.